140 related articles for article (PubMed ID: 12098099)
1. [Rational therapy with hematopoetic growth factors (G-CSF, GM-CSF) for patients in neutropenia].
Kahl C; Leithäuser M; Freund M
Dtsch Med Wochenschr; 2002 Jul; 127(27):1473-8. PubMed ID: 12098099
[No Abstract] [Full Text] [Related]
2. Hemophagocytosis exacerbated by G-CSF/GM-CSF treatment in a patient with myelodysplasia.
Wang S; Degar BA; Zieske A; Shafi NQ; Rose MG
Am J Hematol; 2004 Dec; 77(4):391-6. PubMed ID: 15551287
[TBL] [Abstract][Full Text] [Related]
3. Comparative study of the effects of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor on generation and mobilization of neutrophils in cyclophosphamide-treated neutropenic mice.
Hattori K; Orita T; Oheda M; Tamura M; Ono M
In Vivo; 1996; 10(3):319-27. PubMed ID: 8797034
[TBL] [Abstract][Full Text] [Related]
4. Failure of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor in a patient with Kostmann syndrome.
Hazar V; Ongun H; Yeşilipek MA; Yeğin O
Turk J Pediatr; 1999; 41(1):117-20. PubMed ID: 10770686
[TBL] [Abstract][Full Text] [Related]
5. Effects of a formulary change from granulocyte colony-stimulating factor to granulocyte-macrophage colony-stimulating factor on outcomes in patients treated with myelosuppressive chemotherapy.
Wong SF; Chan HO
Pharmacotherapy; 2005 Mar; 25(3):372-8. PubMed ID: 15843284
[TBL] [Abstract][Full Text] [Related]
6. Granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, and other immunomodulatory therapies for the treatment of infectious diseases in solid organ transplant recipients.
Page AV; Liles WC
Curr Opin Organ Transplant; 2008 Dec; 13(6):575-80. PubMed ID: 19060545
[TBL] [Abstract][Full Text] [Related]
7. Engraftment syndrome after autologous hematopoietic stem cell transplant supported by granulocyte-colony-stimulating factor (G-CSF) versus granulocyte-macrophage colony-stimulating factor (GM-CSF).
Akasheh M; Eastwood D; Vesole DH
Bone Marrow Transplant; 2003 Jan; 31(2):113-6. PubMed ID: 12621492
[TBL] [Abstract][Full Text] [Related]
8. Granulocyte-macrophage colony stimulating factor treatment of febrile neutropenia following remission induction chemotherapy for acute leukemia.
Cucuianu A; Petrov L; Ghiurt A; Vasilache A
Rom J Intern Med; 1996; 34(1-2):97-103. PubMed ID: 8908636
[TBL] [Abstract][Full Text] [Related]
9. Novel strategies for granulocyte colony-stimulating factor treatment of severe prolonged neutropenia suggested by mathematical modeling.
Shochat E; Rom-Kedar V
Clin Cancer Res; 2008 Oct; 14(20):6354-63. PubMed ID: 18927273
[TBL] [Abstract][Full Text] [Related]
10. A randomized trial comparing the combination of granulocyte-macrophage colony-stimulating factor plus granulocyte colony-stimulating factor versus granulocyte colony-stimulating factor for mobilization of dendritic cell subsets in hematopoietic progenitor cell products.
Lonial S; Hicks M; Rosenthal H; Langston A; Redei I; Torre C; Duenzl M; Feinstein B; Cherry J; Waller EK
Biol Blood Marrow Transplant; 2004 Dec; 10(12):848-57. PubMed ID: 15570253
[TBL] [Abstract][Full Text] [Related]
11. Role of granulocyte colony stimulating factor (G-CSF) in chemotherapy induced neutropenia.
Ghalaut PS; Sen R; Dixit G
J Assoc Physicians India; 2008 Dec; 56():942-4. PubMed ID: 19322972
[TBL] [Abstract][Full Text] [Related]
12. Hematopoietic growth factors in cancer chemotherapy.
Lieschke GJ; Foote M; Morstyn G
Cancer Chemother Biol Response Modif; 1997; 17():363-89. PubMed ID: 9551221
[No Abstract] [Full Text] [Related]
13. Granulocyte colony-stimulating factors in the management of chemotherapy-induced neutropenia: evidence based review.
Bhana N
Curr Opin Oncol; 2007 Jul; 19(4):328-35. PubMed ID: 17545795
[TBL] [Abstract][Full Text] [Related]
14. Should prophylactic granulocyte-colony stimulating factor be used in multiple myeloma patients developing neutropenia under lenalidomide-based therapy?
Mateos MV; García-Sanz R; Colado E; Olazábal J; San-Miguel J
Br J Haematol; 2008 Feb; 140(3):324-6. PubMed ID: 18067473
[TBL] [Abstract][Full Text] [Related]
15. [Granulocyte colony-stimulating factor in the newborn neutropenic patient].
Castillo Salinas F; Díaz de Heredia Rubio C; Salcedo Abizanda S; Ferrer Comalat A; Bastida Vila P; Ortega Aramburu JJ; Peguero Monforte G
An Esp Pediatr; 1998 Dec; 49(6):615-8. PubMed ID: 9972625
[TBL] [Abstract][Full Text] [Related]
16. Granulocyte macrophage colony-stimulating factor: current practice and novel approaches.
Buchsel PC; Forgey A; Grape FB; Hamann SS
Clin J Oncol Nurs; 2002; 6(4):198-205. PubMed ID: 12087615
[TBL] [Abstract][Full Text] [Related]
17. Intermittent-low dose G-CSF treatment in a patient with chronic neutropenia.
Yetgin S; Ozbek N
Turk J Pediatr; 1998; 40(3):421-4. PubMed ID: 9763907
[TBL] [Abstract][Full Text] [Related]
18. Clinical applications of granulocyte colony-stimulating factor: an update and summary.
Hübel K; Engert A
Ann Hematol; 2003 Apr; 82(4):207-13. PubMed ID: 12707722
[TBL] [Abstract][Full Text] [Related]
19. Granulocyte growth factors in the treatment of non-small cell lung cancer (NSCLC).
Grossi F; Tiseo M
Crit Rev Oncol Hematol; 2006 Jun; 58(3):221-30. PubMed ID: 16697211
[TBL] [Abstract][Full Text] [Related]
20. Endogenous granulocyte colony-stimulating factor (G-CSF) levels in chemotherapy-induced neutropenia and in neutropenia related with primary diseases.
Kavgaci H; Ozdemir F; Aydin F; Yavuz A; Yavuz M
J Exp Clin Cancer Res; 2002 Dec; 21(4):475-9. PubMed ID: 12636092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]